Literature DB >> 28623514

The potential roles of bacteria to improve radiation treatment outcome.

E Kouhsari1, A Ghadimi-Daresajini2, H Abdollahi3, N Amirmozafari1, S R Mahdavi4,5, S Abbasian1, S H Mousavi6, H F Yaseri7, M Moghaderi8.   

Abstract

Many combined therapies have been proposed to enhance radiotherapy outcome, but they have several limitations. As a new feasible strategy, combination of radiotherapy with bacteria showed a significant positive impact on the tumor treatment and metastasis inhibition. Although probiotic bacteria and radiotherapy alone can be effective in the treatment of different cancers, the combination of these two therapies seems to enhance therapeutic outcome and is cost-effective. Bacterial cells can act as therapeutic/gene/drug delivery vehicles as well as theranostic agents. In this communication, we reviewed current evidences, studies, suggestions, and future-based directions on combination of radiotherapy and bacteria. In another sections, an overview on tumor hypoxia, bacteria in cancer therapy, and combination of radiotherapy and bacteria is presented. A brief overview on trials and animal studies which used bacteria to protect normal tissues against radiotherapy-induced complications is also included.

Entities:  

Keywords:  Bacteria; Outcome; Radioprotector; Radiosensitizer; Radiotherapy; Theranostic

Mesh:

Year:  2017        PMID: 28623514     DOI: 10.1007/s12094-017-1701-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  102 in total

1.  A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation.

Authors:  Mimi Demers; Anne Dagnault; Josée Desjardins
Journal:  Clin Nutr       Date:  2013-10-24       Impact factor: 7.324

2.  Probiotic-based protection of normal tissues during radiotherapy.

Authors:  Hamid Abdollahi
Journal:  Nutrition       Date:  2014-04       Impact factor: 4.008

3.  Pushing radiation therapy limitations with theranostic nanoparticles.

Authors:  Alexandre Detappe; Francois Lux; Olivier Tillement
Journal:  Nanomedicine (Lond)       Date:  2016-04-13       Impact factor: 5.307

4.  Enhanced bacterial tumor delivery by modulating the EPR effect and therapeutic potential of Lactobacillus casei.

Authors:  Jun Fang; Long Liao; Hongzhuan Yin; Hideaki Nakamura; Takashi Shin; Hiroshi Maeda
Journal:  J Pharm Sci       Date:  2014-07-16       Impact factor: 3.534

Review 5.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.

Authors:  J Fensterle; B Bergmann; C L R P Yone; C Hotz; S R Meyer; S Spreng; W Goebel; U R Rapp; I Gentschev
Journal:  Cancer Gene Ther       Date:  2007-12-14       Impact factor: 5.987

8.  Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma.

Authors:  Wei-Ming Wang; Zhi-Li Zhao; Si-Rui Ma; Guang-Tao Yu; Bing Liu; Lu Zhang; Wen-Feng Zhang; Ashok B Kulkarni; Zhi-Jun Sun; Yi-Fang Zhao
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

9.  Radiotherapy combined with an engineered Salmonella typhimurium inhibits tumor growth in a mouse model of colon cancer.

Authors:  Xiande Liu; Shengnan Jiang; Linghua Piao; Feng Yuan
Journal:  Exp Anim       Date:  2016-06-10

10.  Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis.

Authors:  Xiaowei Wang; Yannik Gkanatsas; Jathushan Palasubramaniam; Jan David Hohmann; Yung Chih Chen; Bock Lim; Christoph E Hagemeyer; Karlheinz Peter
Journal:  Theranostics       Date:  2016-03-20       Impact factor: 11.556

View more
  1 in total

Review 1.  New physical approaches to treat cancer stem cells: a review.

Authors:  H Ghaffari; J Beik; A Talebi; S R Mahdavi; H Abdollahi
Journal:  Clin Transl Oncol       Date:  2018-06-04       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.